ArticleVirus research2025
Detection of partial deletions of the human papillomavirus 16 E6 gene in a subset of oropharyngeal and cervical cancers.
Article in Virus research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human papillomavirus 16 (HPV16) is a major carcinogenic HPV type responsible for both cervical cancer (CC) and oropharyngeal cancer (OPC). HPV16 E6 polymorphisms vary by geographic region and are correlated with disease progression. Here, we sought to investigate HPV16 E6 variation in Japanese patients and evaluate its clinical relevance. We enrolled 379 patients with CC and OPC, and subjected 100 CC and 71 OPC samples with HPV16 DNA to E6 sequence analysis. The E6 sequence was partially deleted in 13 (13 %) CCs and 16 (23 %) OPCs. Patients with OPC harboring defective E6 had significantly worse overall survival than those with intact E6. This was observed in univariate analysis but not in multivariate analysis when adjusted for viral load. These findings indicate that low viral load is an independent prognostic factor in patients with OPC, and that E6 deletion is associated with low viral load. By contrast, prognostic differences were not observed in patients with CC. In summary, we report a newly identified gene deletion within the HPV16 E6 region associated with low viral load. These findings will facilitate further studies on the clinical and oncological significance of E6 deletion in patients with HPV16-related malignancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.